Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36

被引：0
|
作者：
Anders Ettrup
Søren Holm
Martin Hansen
Muhammad Wasim
Martin Andreas Santini
Mikael Palner
Jacob Madsen
Claus Svarer
Jesper Langgaard Kristensen
Gitte Moos Knudsen
机构：
[1] Copenhagen University Hospital,Neurobiology Research Unit and Center for Integrated Molecular Brain Imaging (Cimbi)
[2] Rigshospitalet,PET and Cyclotron Unit
[3] Copenhagen University Hospital,Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences
[4] Rigshospitalet,undefined
[5] University of Copenhagen,undefined
来源：
Molecular Imaging and Biology | 2013年 / 15卷
关键词：
PET; Serotonin receptors; Hallucinogenic; Radiation dosimetry; Head-twitch response; Porcine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：376 / 383
页数：7
相关论文
共 50 条
  • [1] Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36
    Ettrup, Anders
    Holm, Soren
    Hansen, Martin
    Wasim, Muhammad
    Santini, Martin Andreas
    Palner, Mikael
    Madsen, Jacob
    Svarer, Claus
    Kristensen, Jesper Langgaard
    Knudsen, Gitte Moos
    MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (04) : 376 - 383
  • [2] Characterization of [11C]CIMBI-36 as a 5-HT2A receptor agonist PET radioligand in the non-human primate brain
    Finnema, Sjoerd
    Ettrup, Anders
    Stepanov, Vladimir
    Nakao, Ryuji
    Amini, Nahid
    Varrone, Andrea
    Knudsen, Gitte
    Halldin, Christer
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S64 - S64
  • [3] Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain
    Finnema, Sjoerd J.
    Stepanov, Vladimir
    Ettrup, Anders
    Nakao, Ryuji
    Amini, Nahid
    Svedberg, Marie
    Lehmann, Charlotte
    Hansen, Martin
    Knudsen, Gitte M.
    Halldin, Christer
    NEUROIMAGE, 2014, 84 : 342 - 353
  • [4] An Improved Radiolabelling Strategy for the 5-HT2A Agonist, [11C]Cimbi-36
    Gillings, Nic
    Lehel, Szabolcs
    Herth, Matthias
    Leth-Petersen, Sebastian
    Madsen, Jacob
    Gabel-Jensen, Charlotte
    Kristensen, Jesper L.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S296 - S296
  • [5] Fenfluramine Reduces [11C] Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain
    Yang, Kai-Chun
    Stepanov, Vladimir
    Martinsson, Stefan
    Ettrup, Anders
    Takano, Akihiro
    Knudsen, Gitte M.
    Halldin, Christer
    Farde, Lars
    Finnema, Sjoerd J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2017, 20 (09): : 683 - 691
  • [6] Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET
    Ettrup, Anders
    Palner, Mikael
    Gillings, Nic
    Santini, Martin A.
    Hansen, Martin
    Kornum, Birgitte R.
    Rasmussen, Lars K.
    Nagren, Kjell
    Madsen, Jacob
    Begtrup, Mikael
    Knudsen, Gitte M.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (11) : 1763 - 1770
  • [7] [11C]-CIMBI5: a novel 5-HT2A agonist PET tracer
    Ettrup, A.
    Palner, M.
    Gillings, N.
    Nagren, K.
    Rasmussen, L. K.
    Keller, S.
    Sibomana, M.
    Begtrup, M.
    Madsen, J.
    Knudsen, G. M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S365 - S366
  • [8] [11C]-CIMBI5: A novel 5-HT2A agonist PET tracer
    Ettrup, Anders
    Palner, Mikael
    Gillings, Nic
    Nagren, Kjell
    Keller, Sune
    Sibomana, Merence
    Rasmussen, Lars
    Madsen, Jacob
    Begtrup, Mikael
    Knudsen, Gitte
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [9] Serotonergic Effects of Viloxazine Measured Using 5-HT2 Agonist Radioligand, [11C]CIMBI-36, in Cynomolgus Monkeys: A PET Imaging Approach
    Garcia-Olivares, Jennie
    Yegla, Brittney
    Zweibaum, David
    Yu, Chungping
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 122 - 123
  • [10] Serotonergic Effects of Viloxazine Measured Using 5-HT2 Agonist Radioligand, [11C]CIMBI-36, in Cynomolgus Monkeys: A PET Imaging Approach
    Garcia-Olivares, Jennie
    Yegla, Brittney
    Zweibaum, David
    Yu, Chungping
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 122 - 123
12345